Silverback Asset Management
DURHAM, NCfiles as SILVERBACK ASSET MANAGEMENT LLC
$27m in 13 US stocks at the end of 30 June 2026. The top 10 are 96.1% of the money. It changed about 20.0% of the portfolio this quarter.
Value
$27m
Stocks
13
Top 10 share
96.1%
Turnover
20.0%
What changed this quarter
New
Bought for the first time this quarter.
- OcugenOCGN1.4% of the fund
Added
Bought more of a stock they already held.
- VroomVRM12.9% of the fund+3%
Cut
Sold some of their stake.
- HarmonicHLIT32.0% of the fund-19%
- Core ScientificCORZ12.6% of the fund-18%
- Tempus AITEM6.2% of the fund-20%
- Magnachip SemiconductorMX1.8% of the fund-55%
- AccurayARAY1.4% of the fund-12%
- Karyopharm TherapeuticsKPTI1.1% of the fund-54%
Sold out
Sold their entire stake.
- NeogenomicsNEO-100%
- Scorpio TankersSTNG-100%
Holdings
- Liveperson
- Share
- 3.4%
- Value
- $921,502
- Shares
- 485,001
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| HarmonicHLIT | 32.0% | $9m | 525,000 | -19% |
| VroomVRM | 12.9% | $3m | 449,236 | +3% |
| Core ScientificCORZ | 12.6% | $3m | 131,600 | -18% |
| TerawulfWULF | 8.9% | $2m | 96,600 | Held |
| AST SpaceMobileASTS | 8.0% | $2m | 24,200 | Held |
| AeroVironmentAVAV | 7.5% | $2m | 12,100 | Held |
| Tempus AITEM | 6.2% | $2m | 28,700 | -20% |
| Liveperson | 3.4% | $921,502 | 485,001 | Held |
| EyePointEYPT | 2.7% | $715,000 | 50,000 | Held |
| Magnachip SemiconductorMX | 1.8% | $473,000 | 100,000 | -55% |
| OcugenOCGN | 1.4% | $382,500 | 250,000 | New |
| AccurayARAY | 1.4% | $373,810 | 1,450,000 | -12% |
| Karyopharm TherapeuticsKPTI | 1.1% | $293,100 | 30,000 | -54% |
Options (10)
- Ishares TRIWM
- Type
- Call
- Value
- $83m
- Contracts
- 275,000
- Definium TherapeuticsDFTX
- Type
- Call
- Value
- $14m
- Contracts
- 294,400
- CytokineticsCYTK
- Type
- Call
- Value
- $9m
- Contracts
- 100,000
- Select Sector Spdr TRXLV
- Type
- Call
- Value
- $8m
- Contracts
- 50,000
- Spdr Series TrustXBI
- Type
- Call
- Value
- $8m
- Contracts
- 50,000
- NutanixNTNX
- Type
- Call
- Value
- $5m
- Contracts
- 100,000
- Lucid GroupLCID
- Type
- Put
- Value
- $3m
- Contracts
- 470,000
- PAR TechnologyPAR
- Type
- Call
- Value
- $3m
- Contracts
- 150,000
- EyePointEYPT
- Type
- Call
- Value
- $1m
- Contracts
- 100,000
- Karyopharm TherapeuticsKPTI
- Type
- Call
- Value
- $977,000
- Contracts
- 100,000
| Company | Type | Value | Contracts |
|---|---|---|---|
| Ishares TRIWM | Call | $83m | 275,000 |
| Definium TherapeuticsDFTX | Call | $14m | 294,400 |
| CytokineticsCYTK | Call | $9m | 100,000 |
| Select Sector Spdr TRXLV | Call | $8m | 50,000 |
| Spdr Series TrustXBI | Call | $8m | 50,000 |
| NutanixNTNX | Call | $5m | 100,000 |
| Lucid GroupLCID | Put | $3m | 470,000 |
| PAR TechnologyPAR | Call | $3m | 150,000 |
| EyePointEYPT | Call | $1m | 100,000 |
| Karyopharm TherapeuticsKPTI | Call | $977,000 | 100,000 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 6.7% since 30 June 2025.
Where the money is
Technology40.0%
Financial services21.5%
Retail & consumer12.9%
Media & telecom8.0%
Industrials7.5%
Health care6.6%
Other3.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.